Status:
COMPLETED
MIP Versus PCNL for Kidney Stone Disease
Lead Sponsor:
University of California, San Diego
Conditions:
Kidney Stone
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The decision to use standard percutaneous nephrolithotomy (PCNL) versus mini-percutaneous nephrolithotomy (MIP) has been a subject of much debate in the urological community. The investigators propose...
Detailed Description
Presurgical management will follow the standard of care and patients with active urinary tract infections will be treated prior to kidney stone surgery. After the informed consent process, the subject...
Eligibility Criteria
Inclusion
- Patients with planned PCNL and a preoperative CT scan
- Urologist obtained access and prone positioning during surgery
- Tract dilation performed either using balloon dilator or a single step mini-PCNL dilation
- Age: ≥18 years' old
- Stone size: 10-25mm
- Gender: Male and female patients
- Patients of all ethnic backgrounds
- Capable of giving informed consent
- Capable and willing to fulfill the requirements of the study
- Pre-existing indwelling nephrostomy tube or ureteral stent permitted
Exclusion
- Anticoagulated or history of coagulopathy (with the exception of daily 81 mg aspirin)
- Conversion to open procedure
- Multiple access tracts
- Inability to give informed consent or unable to meet requirements of the study for any reason
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 7 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04767919
Start Date
January 1 2021
End Date
June 7 2024
Last Update
March 27 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Phoenix, Arizona, United States, 85054
2
University of California, San Diego, Medical Center
San Diego, California, United States, 92103
3
Cleveland Clinic
Cleveland, Ohio, United States, 44195
4
Ohio State Unversity
Columbus, Ohio, United States, 43210